Biological Effects of Treatment With Resveratrol in ART Patients
Launched by UNIVERSITY OF PERUGIA · May 8, 2020
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
The purpose of the study is to evaluate the effect of a new nutraceutical formulation containing resveratrol (trademark Genante) on gamete quality in order to improve the reproductive protocols during Assisted reproductive technology (ART) protocols.
The study is a randomized, single blind, parallel, comparative, experimental study during the pre-treatment before in vitro fertilization-embryo transfer (IVF-ET). A total number of 100 patients will be enrolled: 50 patients with a pretreatment control group (control group) and 50 patients with experimental pretreatment study group (resveratro...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with a diagnosis of infertility
- • BMI between 18 and 30 kg/m2,
- • regular uterine cavity
- • normal thyroid function
- • normal blood parameters
- Exclusion Criteria:
- • primary or secondary ovarian failure
- • patients who adhered to Bologna Criteria (at least two of the following: advanced maternal age \>40, less than 3 oocytes recovered in previous attempts, abnormal ovarian reserve test)
- • presence of ovaries inaccessible to the oocyte pick-up,
- • persistent ovarian cysts \> 20 mm,
- • presence of sactosalpinx
- • heterologous fertilization, significant systemic disease or other situations unsuitable for ovarian stimulation
About University Of Perugia
The University of Perugia, a prestigious academic institution located in Italy, is dedicated to advancing medical research and clinical innovation through its robust clinical trial initiatives. With a strong emphasis on interdisciplinary collaboration and ethical standards, the university aims to contribute to the development of novel therapeutic strategies and improve patient outcomes. Leveraging its extensive network of healthcare professionals and cutting-edge facilities, the University of Perugia fosters a dynamic research environment that supports both local and international clinical studies, ultimately enhancing the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Perugia, Umbria, Italy
Patients applied
Trial Officials
Sandro Gerli, MD
Principal Investigator
University Of Perugia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials